FDA — authorised 24 September 1954
- Application: NDA009495
- Marketing authorisation holder: GLAXOSMITHKLINE
- Local brand name: MAREZINE
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 Marezine in United States
FDA authorised Marezine on 24 September 1954
Marketing authorisations
FDA
- Marketing authorisation holder: GLAXOSMITHKLINE
- Status: approved
Marezine in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in United States
Frequently asked questions
Is Marezine approved in United States?
Yes. FDA authorised it on 24 September 1954; FDA has authorised it.
Who is the marketing authorisation holder for Marezine in United States?
GLAXOSMITHKLINE holds the US marketing authorisation.